Thank you for submitting your manuscript for consideration by The EMBO Journal. It has now been seen by three referees whose comments are shown below.
As you will see from the reports, all referees express interest in the findings reported in your manuscript but also raise a number of critical concerns that you will have to address in full before they can support publication of a revised manuscript.
A clear issue raised by all three refs is the need to substantially restructure and shorten the manuscript to focus it on the core message of antagonistic regulation of CirA by Hfq and RyhB. In addition, ref #1 and #3 point to a number of inconsistencies between the presented data and the suggested model and ask you to further clarify the mechanism underlying activation of translation as well as the requirement for Hfq in this process. Another issue relates to the 'functional translatability' of the in vitro assays as exemplified by the concerns raised about the toe-printing assay. Regarding the broader functional implications of your work, we would ask you to either provide additional experimental evidence for the role for RyhB in regulation of colicin sensitivity as requested by ref #1 or to demonstrate the existence of a Fur, RyhB, cirA feed-forward loop as suggested by ref #2. In addition, all three refs raise a number of additional concerns that need to be addressed in full. 4. Fig. 4A : it is unclear why in the absence of degradosome assembly, an increase in RyhB but not in cirA mRNA levels is observed. 5. Fig. 4B : Do we know whether the observed upregulation of cirA mRNA in lane 8 (no RyhB, RNase E inactivated) is due to transcript stabilization or increased transcription from the cirA promoter? 6. Fig. 5 : The choice of the "transcriptional" and the "translational" cirA fusions as reporters is misleading. The same insert comprising the upstream region of the gene and the first 32 nt of the coding sequence (cf. M&M part, ll. 1066-1069) is ligated into two different reporter plasmids. The pFRΔ-based construct is not optimal to monitor transcriptional activity. For a true transcriptional reporter, the fusion should not depend or contain the translation initiation site of the gene tested. In any case, if the fusion reported solely transcriptional changes, the results would be inconsistent with the experiments described in Fig. S1 . The same fusions are again used in Fig. 6 . 7. Fig. 7 : These in vitro experiments are meant to support the model that RyhB dislodges Hfq from the cirA mRNA, and so increases ribosome binding. While the results obtained are technically clean and can be interpreted, in principle, as fully supporting the authors' model, they do not make much sense with respect to a regulation in vivo without a further discussion of numbers. For example, in panel 7A, it takes 200 nM Hfq to suppress 30S subunit binding to the cirA mRNA but what is the concentration of the latter? The M&M section gives say 2 pmol mRNA but gives no reaction volume so it is difficult to understand the stochiometry of Hfq and mRNA. 8. Fig. S4 : In the absence of Hfq, the authors observe a reduction in toeprint formation dependent on RyhB binding. While the authors claim that RyhB cannot further enhance 30S association in the absence of Hfq (ll. 424 ff.), it is unclear why RyhB (but not the mutant RyhB1) can influence toeprint formation from the distance. How does this result fit with the observation that RyhB can activate cirA in the absence of Hfq in vivo? 9. Fig. 8 : With regulations so small (in the 1.3-fold range), it would be important to show that Hfq and RyhB do not regulate a non-cognate mRNA in this toeprinting assay. 10. Fig. 9 : The role of RyhB in the regulation of colicin sensitivity is not addressed in much detail. The authors observe a growth defect in cells (presumably) expressing the sRNA, however these cultures recover at later stages of growth. The authors can exclude a suppressor mutation, thus it would be helpful to determine the levels of RyhB/cirA at some critical points during this experiment.
Minor points:
-Paginate the manuscript.
- Fig. 1C : decay should be plotted logarithmically over linear time.
- Fig. 2A : drawing of the figure should be improved. Use different fonts and colour.
- Fig. 2A : can the structure drawn be supported by a conservation/covariation analysis of the suggested single-stranded and paired regions? - Fig. 4B : is there an explanation for the strong effect of temperature on the regulation of cirA by RyhB? In ll. 1/2, sRNA levels are constant, but stabilization is only observed at lower temperature. Is there a difference in promoter activity? If yes, the authors should consider a reporter under the control of a temperature-insensitive promoter.
- Fig. 7 : Hfq concentrations should be consistently given as nanomolar or micromolar.
-ll. 54/55: something is missing here. The authors start to describe the composition of a colicin gene cluster, but the term "immunity protein" is missing.
-l. 60: "colicins" should read "colicin"
The EMBO Journal Peer Review Process File -EMBO-2013-84565 © EMBO 4 -l. 109: the listed references look like a reading list, and it is unclear which of them supports which point in the relevant sentence.
-l. 113: "condtions" should read "conditions" -ll. 138-9: Which 'active role' was confirmed? Rephrase the sentence for clarity.
-l. 144: correct to 'quantitative Real Time-PCR (qRT-PCR)' -l. 201: "proceed" should read "proceeded" -l. 240: "Fusions activity" should read "Fusion activity" -l. 250: I do not think that these RNase E mutants "were engineered" in this study.
-l. 261: "thermosenstive" should read "thermosensitive".
-ll. 262-6: The logic, results and conclusions of this experiment must be better explained.
-l. 386: correct "it could expected" -l. 390: correct "it could then be expect" -ll. 382-393: this paragraph is really hard to read. On the one hand, the authors claim that region -40 to -12 is not cleaved by RNase I due to the formation of a stem-loop, but on the other hand susceptible to PbAc treatment due to instability of the base-pairing. The authors should try to make a clear point here.
-ll. 453-456: The observed "increased cleavage of nucleotides -41 to -38 and -34 to -31" (Fig. 8B ) occurs also independent of Hfq if only RyhB was present.
-l. 573: correct "elemen t" -l. 573: correct "Shine-Darlgarno"
Referee #2:
In this study Salvail et al. examined the ability of the RyhB small RNA to activate translation of the cirA mRNA. Unlike other examples of positive regulation where the small RNA acts to prevent the formation of an inhibitory secondary structure, RyhB pairing promotes changes in the cirA secondary structure that relieve the inhibitory binding of the RNA chaperone Hfq. The manuscript represents a significant amount of work and the results are interesting. However, the authors need to address the following.
1. The text of the manuscript should be shortened by at least one-third throughout. The current manuscript is unnecessarily difficult to read due to the lengthy descriptions. For example, while there is a detailed description of colicins in the introduction, this section is not very clear.
2. The authors point out that Fur, RyhB and cirA are in an interesting feedforward loop and speculate about the possible physiological consequences of the loop. The study would be a more substantial contribution if the authors actually tested their predictions. (The rationale for delaying cirA expression when cells experience iron starvation to express cirA only when absolutely necessary makes sense, but what are the benefits of delaying repression upon a shift from iron-poor to iron-rich conditions.) This data could replace the section on colicin Ia sensitivity since this last section is a bit of an outlier from the rest of the data presented in the paper. Figure 2B should be part of Figure 3 . The authors should also comment on the region of RyhB involved in base pairing with cirA compared to the RyhB regions involved in base pairing with other targets.
-- Figure 3B : The cirA Northern is not very convincing. The OmrA and OmrB panels in Figure 6A also are not optimal.
-- Figure 7A : The authors should examine the effects of a control protein in the toe print assay (to demonstrate that the loss of ribosome binding is a specific effect).
4. Given that evidence for Hfq binding to sites II and III is subtle, the authors should assay lacZ fusions in which the Hfq binding sites have been mutated. The prediction from the model presented in the paper is that expression from these mutants should not be changed in an hfq deletion background.
More minor comments:
5. The authors need to be more explicit about the following: --They should specify that "shiA" not regulated by Fur in the introduction.
--They need to acknowledge that some of the unexplained regulation of cirA could be due to the action of another small RNA given that that many mRNAs are regulated by multiple small RNAs.
--The type of lacZ fusions being assayed should be spelled out (the "tic" is easy to miss).
6. There are a number of typographical errors (not a complete list): --Lines 54-55: "...encode a colicin, which is a protein that protects..." --Line 106: "stimulate" --Line 113: "condtions" --Lines 516-517: "series of experiment" --Line 575: "Shine-Dalargno" 7. Strains and plasmids table should be given as Supplementary Data.
Referee #3:
This paper reports the study on post-transcriptional regulation of cirA by an Hfq-binding small RNA RyhB in E. coli. The authors first showed that RyhB is required for the expression of cirA mRNA encoding CirA, a siderophore receptor involved in ferric ion uptake and the cirA mRNA is stabilized by RyhB. They showed evidence that RyhB promotes CirA expression through pairing with cirA mRNA and protects the cirA mRNA from RNase E degradation. The data suggest that RyhB pairing with cirA mRNA leads to increased translation resulting in the protection and accumulation of fulllength cirA mRNA. In addition, the authors showed evidence that Hfq represses cirA mRNA translation in the absence of RyhB by preventing ribosome binding and RyhB pairing with cirA mRNA stimulates ribosome binding. Finally, the authors showed that RyhB increases the sensitivity to colicin Ia through cirA activation.
This work demonstrates convincingly that the Fur-regulated cirA gene is positively regulated by RyhB at post-transcriptional level, revealing the presence of an intriguing Fur-RyhB-cirA regulatory circuit. Furthermore, the proposed mechanism by which RyhB activates the cirA mRNA is quite interesting. The findings expanded our view regarding how bacterial Hfq-binding sRNAs act in bacterial cells. I have criticisms/comments on the data and the organization of the manuscript.
Comments: 1) First of all, the manuscript is too long and the argument is too diverse. Some data seem to be less informative. I think that the manuscript should be reorganized by focusing on the cirA regulation by RyhB and by trimming drastically throughout. The followings can be deleted or described more concisely: a) the argument concerning colicin/CirA and the detailed data regarding the colicin sensitivity test because it is already known that CirA is a target of colicin Ia; b) some data and description on lacZ fusion experiments are less informative and could be deleted; c) the results of Figs. 7 and 8 could be described more concisely.
2) The data show overall a good correlation between RyhB expression and cirA expression in the absence of Fur. However, the cirA is little expressed while RyhB well expressed at OD600=0.3 in cells lacking fur gene (Fig. 1C , lane 7). This is quite confusing.
3) The cirA mRNA stabilization by RyhB (Fig. 1D ) is too moderate to explain the dramatic activation of cirA mRNA by RyhB shown in Fig 1B and 1C . 4) Fig. 6A shows that the cirA mRNA is highly expressed in the absence of Hfq even without RyhB, suggesting that RyhB promotes the cirA expression simply through relieving Hfq repression. On the other hand, the Fig. 6C shows the cirA mRNA expression require RyhB even in the absence of Hfq. Thus, two experiments appear to be inconsistent each other. 5) RyhB-cirA pairing can activate the cirA expression by antagonizing Hfq repression and/or by increasing the ribosome accessibility to the cirA mRNA. It is frustrating that the data are confusing and not matured yet to make this important point clear. One simple important but experiment is to examine the effect of hfq deletion on CirA protein expression.
6) The authors propose antagonistic function between Hfq and RyhB. I think this proposal is not appropriate because Hfq is essential for RyhB to base pair with cirA to activate the cirA translation. Authors' answer. This is a very good comment. We have shortened the introduction, especially the section on colicin to make it more focused. et al., 2003; Desnoyers et al., 2009 and Prévost et al., 2011) , there might be less RyhB codegradation as well, thereby explaining increased RyhB accumulation in rne131 background.
The level of cirA mRNA observed in WT background at the OD tested ( Figure S2A , lane 1) might correspond to maximum expression for cirA and the level of RyhB expressed in the same conditions seems sufficient to promote this level of expression, thereby explaining why there is no increased cirA accumulation in rne131 background, despite increased RyhB expression. In other words, past a certain level of RyhB expression (WT levels, lane 1), cirA mRNA levels cannot be further increased by expressing more RyhB ( Figure S2A , lane 3).
Fig. 4B: Do we know whether the observed upregulation of cirA mRNA in lane 8 (no RyhB, RNase E inactivated) is due to transcript stabilization or increased transcription from the cirA promoter?
Authors' answer. [ Fig 4B is now Fig S2B] Since the incubation at 44°C with (compare lanes 5 and 6) or without (compare lanes 1 and 2) RNase E inactivation both result in a decrease of cirA accumulation in WT backgrounds (ryhB+ cells), we doubt that RNase E inactivation (and/or temperature switch to 44°C) promotes an increase of cirA promoter activity even if it has not been addressed experimentally.
We show in our manuscript that the stabilization of cirA by RyhB is promoted by translational activation. Moreover, RNase E has been shown by Guillier et al., 2008 (Mol Microbiol) to be involved in the rapid turnover of cirA upon translational repression by OmrA/B. Thus, we are quite confident that it is RNase E that promotes the rapid degradation of cirA when RyhB is not expressed, thereby explaining the increased accumulation of cirA upon RNase E inactivation in a DryhB background. Fig. S1 . The same fusions are again used in Fig. 6 .
Authors' answer. [Fig 5 is now Fig 4] The pFRD and pRS1551 have been proved to be reliable genetic tools in previous studies from our lab to distinguish between transcriptional and translational effects of RyhB-mediated or riboswitch-based regulations (Prévost et al., Mol Microbiol., 2007, Desnoyers et al., Genes and Dev, 2012; Caron et al., PNAS, 2012) . Removing cirA translation initiation site from our transcriptional fusion, as proposed in point 6, would make the fusion insensitive to RyhB trans-regulation, given the fact that RyhB interaction site is located in this region. Using such a fusion would be useful to determine if the RyhB effect is direct or indirect (e.g. effect on the promoter), which is addressed in a convincing way in Figure 4C and D.
The point of using both transcriptional and translational fusions was to determine if the stabilization of cirA mRNA by RyhB was occurring through translational activation or through a translationindependent mechanism. Since the transcriptional fusion harbours two Shine-Dalgarno sequences (one for cirA and one for lacZ) and the translational fusion harbours only one Shine-Dalgarno sequence for cirA and lacZ, the translation of lacZ totally depends on cirA translation. Therefore, if cirA activation occurs through translation activation, we should expect a higher RyhB effect on cirA translational fusion than on cirA transcriptional fusion, which is the case, as shown in Figure 4A and B. The same rationale was applied to demonstrate that RyhB activates shiA through translational activation (Prévost et al., Mol Microbiol., 2007) . There was a stronger RyhB effect on the shiA translational fusion (constructed with pRS1551) as compared to the transcriptional fusion (constructed with pFRD). Fig 6] The concentration of cirA used in the assay is 0.2 mM. Therefore, it takes equimolar amounts of Hfq and cirA (Hfq:cirA molar ratio, 1:1) to observe 2.2-fold reduction of 30S binding. To make it clearer, we have added the cirA mRNA final concentration in the figure's legend.
Authors' answer. [Fig 7 is now

Fig. S4: In the absence of Hfq, the authors observe a reduction in toeprint formation dependent on RyhB binding. While the authors claim that RyhB cannot further enhance 30S association in the absence of Hfq (ll. 424 ff.), it is unclear why RyhB (but not the mutant RyhB1) can influence toeprint formation from the distance. How does this result fit with the observation that RyhB can activate cirA in the absence of Hfq in vivo?
Authors' answer. [ Fig S4 is now Fig S6] The fact that RyhB, but not RyhB1, represses 30S binding indicates that the effect depends on RyhB specific pairing to cirA instead of being a sequestration of the ribosome away from cirA mRNA through non-specific interactions of the 30S with the added sRNA (RyhB or RyhB1). Since RyhB represses 30S binding to cirA only when added in excess amounts (0.4 mM; 2-fold and 0.8 mM; 4-fold), it might be an in vitro artefact which might not reflect what is really happening in vivo. Indeed, we observe in Figure 6C that RyhB increases cirA mRNA levels in the absence of Hfq, which does not fit with our in vitro results (if RyhB would really prevent 30S binding in vivo, when expressed in the absence of Hfq, we would expect cirA destabilization instead of increased accumulation as observed in Figure 5C ).
We could expect this increased accumulation of cirA mRNA upon RyhB expression in the absence of Hfq to occur via a stabilization independent of translation activation. Nevertheless, this RyhB positive effect on cirA in the absence of Hfq remains elusive for now. However, it is worth to mention that sustained expression of RyhB through induction of pBAD-ryhB with 0.1% arabinose, as it was done for Figure 5C , does not represent homeostatic amounts of RyhB accumulating in an iron-dependent manner as it is the case for experiments performed in iron-free M63 minimum medium (e.g. Figures 1C; S2 ; 4B and D and 5A and B). Indeed, the levels of RyhB accumulating through induction with 0.1% arabinose are far higher than the levels observed in iron-free medium. We can therefore expect nonspecific effects, especially in a background that is far for WT conditions (i.e. Dfur DryhB Dhfq). The fact that removing hfq in a DryhB background results in WT levels of cirA translational fusion ( Figure 5B ) reinforces our main hypothesis that RyhB activates cirA expression mainly, if not solely, by counteracting Hfq negative regulation in homeostatic conditions. This Hfq counteraction was reproduced in toeprinting in Figure 7A using Hfq and RyhB/RyhB1 concentrations that are below the equimolar amount with cirA mRNA (150 nM Hfq; 150 nM RyhB/RyhB1; 200 nM cirA).
Fig. 8. With regulations so small (in the 1.3-fold range), it would be important to show that Hfq and RyhB do not regulate a non-cognate mRNA in this toeprinting assay.
Authors' answer. [Fig 8 is now Fig 7] This is an excellent comment. To address this, we have performed a toeprint on lpp mRNA that has been previously used as a non-target of Hfq (Vytvytska et al., Genes and Dev., 2000) . (NEW Fig S4A and B) .
The toeprinting of Figure 7 has been repeated with the lpp mRNA that is used as a non-Hfq target in Vytvytska's paper. It is shown in the paper that Hfq does not repress 30S binding in toeprinting even at high molar ratios (up to 1:30 lpp:Hfq molar ratios). Of note, there is no RyhB effect on lpp according to the microarray data from Massé et al., 2005. The lpp mRNA should then be a good non-cognate mRNA.
Fig. 9: The role of RyhB in the regulation of colicin sensitivity is not addressed in much detail. The authors observe a growth defect in cells (presumably) expressing the sRNA, however these cultures recover at later stages of growth. The authors can exclude a suppressor mutation, thus it would be helpful to determine the levels of RyhB/cirA at some critical points during this experiment.
Authors' answer. [Fig 9 is now Fig 8] We agree with the reviewer and we would like to point out that conditions of culture used for this experiment were the same as for Figure 1C (Iron-free minimal medium). The Northern shows that RyhB as well as cirA mRNA are expressed in WT conditions at the OD 600 for which we observe the colicin killing effect. The fact that removing RyhB results in a colicin resistance phenotype that is basically the same as the DcirA strain, together with all the results presented in the manuscript showing that RyhB is essential for cirA mRNA accumulation as well as for CirA expression, strongly suggests that RyhB is responsible for promoting colicin Ia sensitivity upon iron starvation. We have added the sentence : "For a determination of the levels of RyhB and cirA RNAs performed in the same growth conditions, please refer to Fig 1C" in the legend of Fig 8. As explained in the manuscript (last section of the Results), the fact that WT culture recover from the treatment at late stages of growth might be explained by cells that were not contacted by the colicin at the beginning of the treatment. For example, if the amount of colicin Ia we add to the flask contacts only two-thirds of the cells, the one-third remaining that is not exposed to colicin Ia will keep dividing. However, the other cells will be killed rapidly. If two-thirds of the cells are killed and only one-third is dividing, the OD 600 will indeed increase slowly over time as compared to untreated WT cells in which all the cells are dividing normally. The growth recovery we observe for treated WT cells at the later stages of growth might be the cells that were not initially contacted by the colicin Ia that keep dividing.
Minor points:
Paginate the manuscript.
Authors' answer. Done.
Fig. 1C: decay should be plotted logarithmically over linear time.
Fig. 2A: drawing of the figure should be improved. Use different fonts and colour.
Authors' answer. We improved the Figure 2A by including colour and different fonts. Authors' answer. Protein BLAST suggests that CirA is mostly restricted to E. coli and Shigella species, which makes sense assuming that the main substrate of the permease is the colicin Ia, for which the killing action is mainly restricted to E. coli and closely related species. The sequence (so the structure) of cirA 5'-UTR is pretty much the same for E. coli and Shigella, which is in itself not surprising considering the fact that both species have very similar genomes. It is then difficult to support the structure prediction by any conservation/covariation analysis. Of note, CirA is present in Salmonella. Despite the fact that cirA 5'-UTR sequence in this species resembles the one from E. coli and Shigella, it seems to have some differences. However, because no transcriptional start sites have been determined for Salmonella cirA, no reliable structure prediction, and then no conservation/covariation analysis, can be performed. Fig S2B] The negative effect of high temperature (44°C) on cirA expression remains elusive. As explained above in point 5, it is probably not resulting from increased RNase E activity, since this effect is also observed in rne-3071 background. We could indeed expect a negative effect of high temperature on cirA promoter activity. However, we consider further investigation of the temperature effect on cirA expression, and therefore the use of a reporter under the control of a temperature-insensitive promoter, as unnecessary since all the required controls and conditions were included in Figure 4B to be able to distinguish between RNase E inactivation and high temperature effects (see point 5 for a complete analysis of Figure  4B ). In other words, the point here is not to determine the cause of the temperature effect on cirA expression, but instead to consider this effect in our analysis of Figure 4B . -ll. 54/55: something is missing here. The authors start to describe the composition of a colicin gene cluster, but the term "immunity protein" is missing.
Authors' answer. [Fig 4B is now
-l. 113: "condtions" should read "conditions"
-ll. 138-9: Which 'active role' was confirmed? Rephrase the sentence for clarity.
We have rephrased the sentence to "Moreover, our results confirmed the role of RyhB in gene activation in addition to its role as a gene silencer".
-l. 144: correct to 'quantitative Real Time-PCR (qRT-PCR)'
l. 201: "proceed" should read "proceeded"
l. 240: "Fusions activity" should read "Fusion activity"
l. 250: I do not think that these RNase E mutants "were engineered" in this study.
Authors' answer. We rephrased the sentence to "two mutants of RNase E were used".
l. 261: "thermosenstive" should read "thermosensitive".
ll. 262-6: The logic, results and conclusions of this experiment must be better explained.
Authors' answer. We have rewritten the section to make it clearer: "The other mutant (rne-3071) was a thermosensitive allele where RNase E becomes inactive at non-permissive temperature (44°C for 15 min) (McDowall et al., 1993) . In these experiments, cirA transcript accumulated to levels similar to WT in the absence of RyhB expression when RNase E was inactivated following a 15 min-exposure of the rne-3071 ΔryhB strain at 44°C (Fig 4B, lanes 6 and 8) . These data led us to the conclusion that RNase E was responsible for the turnover of cirA mRNA in the absence of RyhB".
l. 386: correct "it could expected"
-l. 390: correct "it could then be expect"
Authors' answer. Done. -ll. 382-393: this Authors' answer. Very good observation from the reviewer. To answer to this point properly, we have added the following lines of explanation at the end of the paragraph: "Despite that both PbAc and RNase I have a preference of cleavage for unstructured RNA, RNase I activity is generally considered as more sensitive to secondary structures than PbAc (Pan, 2001; Ziehler and Engelke, 2001) . It then explains higher cleavage of nucleotides -33 to -31 by PbAc than RNase I". occurs also independent of Hfq if only RyhB was present. Fig 7B] We have added the following sentence: "Notably, these secondary structure changes are also observed when RyhB is added in the absence of Hfq (compare lanes 5 and 6), suggesting they do not require Hfq to occur."
Authors' answer. [Fig 8B is now
-l. 573: correct "elemen t"
-l. 573: correct "Shine-Darlgarno"
Referee #2:
In this study Salvail et al. examined 
The text of the manuscript should be shortened by at least one-third throughout. The current manuscript is unnecessarily difficult to read due to the lengthy descriptions. For example, while there is a detailed description of colicins in the introduction, this section is not very clear.
Authors' answer. This is a very good comment that resonated with reviewer #1, comment #1. As mentioned above, we have shortened the introduction, especially the section on colicin to make it more focused on the content of the manuscript. Authors' answer. The editor asked us to either provide additional experimental evidence for the role of RyhB in the regulation of colicin sensitivity or to demonstrate the existence of a Fur, RyhB, cirA feed-forward loop. We chose the first option as several results were already addressing this point.
The authors point out that
It is worth to mention that a comprehensive study of the feedforward loop would be quite difficult to achieve given the fact that RyhB is essential for CirA expression upon iron starvation. It would then be difficult to assess the contribution of RyhB to the dynamic of induction by removing the sRNA from the loop as Beisel et al. did it with Spot42 in Mol. Cell in 2011. In other words, since ryhB mutant strain expresses really low levels of CirA protein upon iron starvation, it will be difficult to monitor how many time it takes for DryhB cells to fully express CirA upon addition of a iron chelator (e.g. 2,2-dipyridyl) as compared to WT cells.
Potential benefits of delaying cirA repression upon a shift from iron-poor to iron-rich conditions are briefly discussed in the Discussion section (lines 649-651). We suggest that it would be a way for bacteria to turn off CirA expression (and then DHB and Fe 3+ -DHBS uptake) only when the intracellular iron starvation is totally relieved and not only in response to transient increases of intracellular iron concentration. Assuming the potential benefits of colicin sensitivity upon iron starvation as discussed in the Discussion, we could also hypothesize that interrupting rapidly colicin sensitivity in response to transient iron pulses could be detrimental for a cell population experiencing iron scarcity.
Better or additional data should be shown for some figures:
-- Figure 1B : Size markers should be shown for the first cirA Northern presented.
Since only full-length cirA mRNA is monitored in the Northern blot analysis, we do not consider necessary to include a size marker to the Figure. Authors' answer. We have move Fig 2B into Fig 3 and we have added the following sentence: "Interestingly, the region of RyhB potentially involved in the base pairing with cirA (41-51) is part of the sRNA central loop, which is involved in the base pairing with all the other RyhB mRNA targets characterized so far (Peer and Margalit, 2011).
-- Figure 3B : The cirA Northern is not very convincing. Fig 3C] We agree that the cirA bands in lanes 5 and 6 are not that sharp. However, it nonetheless recapitulates pretty well the pBAD-ryhB-mediated activation of cirA in Dfur DryhB cells as shown in Figure 1B . It is worth to mention that the point of Figure 3C is to show the absence of RyhB1-mediated activation of cirA expression, which is demonstrated, in our opinion, in a really convincing way by the Northern blot analysis, but also by the b-galactosidase assay in Figure 3D . The pBAD-ryhB condition (lanes 4-6) was included in Figure 3C to better contrast the RyhB-mediated activation of cirA with the absence of RyhB1-mediated activation of cirA.
Authors' answer. [Fig 3B is now
-The OmrA and OmrB panels in Figure 6A also are not optimal.
Authors' answer. [ Fig 6A is now Fig 5A] We do not expect OmrA/B to be strongly expressed under these conditions as OmrA/B expression levels in M63 minimal medium are really low (Guillier and Gottesman, 2006) . Northern membranes then need to be exposed for a long period of time in order to detect a signal, thus explaining the granular background of the membrane. Also, the poor OmrA/B expression in the absence of Hfq (see lanes 3 and 4) correlates with previous reports (Guillier and Gottesman, 2008; Holmqvist et al., 2010) .
Authors' answer. [ Fig 7A is now Fig 6A] We consider this an excellent suggestion. As a control, we have performed toeprinting on lpp mRNA, which was shown to be not regulated by Hfq (Vytvytska, 2000) , in the presence of increasing Hfq concentration. As shown in Fig S4, while the lpp mRNA is only slightly affected by 200 nM Hfq (repressed to 90%), the cirA mRNA is repressed to 45%. Thank you for submitting a revised version of your manuscript to The EMBO Journal. It has now been seen by all three original referees whose comments are shown below.
Given that evidence for
As you will see, while the referees acknowledge your efforts to strengthen the conclusions made in your study, and are consequently broadly in favour of publication, they all emphasize the need for you to substantially shorten and clarify the manuscript text (either directly in their comments as provided below or in their recommendations to the editorial office).
An extensive shortening of the manuscript was already requested in the initial decision letter and as you will notice the absence of such shortening in the current version has caused substantial irritation with ref #3, who at this stage does not support publication of the revised manuscript. The EMBO Journal guidelines furthermore limit manuscript length to around 55.000 characters (including spaces) and since your manuscript currently contains almost 90.000 characters it is vital that you perform a substantial shortening of all sections (at least 25% reduction of current manuscript length) before we can take any further steps towards publication.
In addition, I have to ask you to address the following minor editorial issues:
-> include a conflict of interest statement and an outline of author contributions -> provide information on the nature of error bars as well as the number of replicates underlying statistical calculation (n≥3) in the legend for the following figures: 1A+D, 3D, 4A-D, 5B+D, 6D and 7A as well as for all relevant supplementary figures.
-we now also encourage the publication of source data, particularly for electrophoretic gels and blots, with the aim of making primary data more accessible and transparent to the reader. We would need 1 file per figure (which can be a composite of source data from several panels) in jpg, gif or PDF format, uploaded as "Source data files". The gels should be labelled with the appropriate figure/panel number, and should have molecular weight markers; further annotation would clearly be useful but is not essential. These files will be published online with the article as a supplementary "Source Data".
In light of the recommendations from the referees I would invite you to submit a revised version of your manuscript addressing all of the issues outlined above. Thank you again for giving us the chance to consider your manuscript for The EMBO Journal, I look forward to your revision.
REFEREE REPORTS:
Referee #1:
The revised version of this manuscript has sufficiently addressed the majority of the previous points of criticism. There are a few typos here and there that need to be fixed still. Figures S8 and S9 would be good to have in the main manuscript as they present important data but I will leave this to the authors' discretion.
The authors have made a reasonable effort to address the reviewers' comments, which has improved this study. I think further effort to improve the readability of the manuscript would be appreciated by general readers.
--The text could be condensed even further.
--Long sections could be subdivided with additional subheadings.
--Paragraphs could be more focused with clear topic sentences (as just one example, the sentence beginning on line 102 "RyhB also promotes..." should be in the subsequent paragraph on RyhB function as an activator).
